Luxa Biotechnology
Fort Lee
About Luxa Biotechnology
Luxa Biotechnology (LuxaBio) is a clinical-stage biotechnology firm developing a unique adult RPE stem cell (RPESC) therapy for dry AMD.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.0M
- Last round: Grant (May 2024)
- Website: luxabiotech.com
- Phone: 201-482-4093
Industries & Categories
Clinical Trials, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/luxa-biotechnology-72041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.